These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1508360)

  • 1. [Neuroleptic malignant syndrome. Problems of differential diagnosis. Description of a clinical case].
    Musto P; Vinay P; Coalda M; Bono D; Vai G
    Minerva Anestesiol; 1992; 58(7-8):459-64. PubMed ID: 1508360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The malignant neuroleptic syndrome and malignant hyperthermia].
    Mitterschiffthaler G; Hackl JM; Neumann R
    Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroleptic malignant syndrome: a missed diagnosis?
    Saunders BP; Trewby PN
    Br J Clin Pract; 1993; 47(3):170-1. PubMed ID: 8347450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome].
    Murak E
    Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catatonic syndrome and neuroleptic malignant syndrome].
    Ruzikowska A
    Psychiatr Pol; 1999; 33(3):415-25. PubMed ID: 10786241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome: a review and report of six cases.
    Kasantikul D; Kanchanatawan B
    J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome.
    Bristow MF; Kohen D
    Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What do we know today about neuroleptic malignant syndrome?].
    Nyquist OG
    Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2879-82. PubMed ID: 8975402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome: need for early diagnosis and therapy.
    Khan HM; Syed NA; Sheerani M; Khcalani B; Kamal A; Wasay M
    J Ayub Med Coll Abbottabad; 2006; 18(1):17-21. PubMed ID: 16773963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome: a review of the literature.
    Pearlman CA
    J Clin Psychopharmacol; 1986 Oct; 6(5):257-73. PubMed ID: 2877012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M; Marzański M
    Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome in the elderly.
    Leipsic JS; Abraham HD; Halperin P
    J Geriatr Psychiatry Neurol; 1995 Jan; 8(1):28-31. PubMed ID: 7710643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.